Resources

Download

Buprenorphine Data Waiver (SAMHSA)

HHS Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder changed on April 28, 2021. Practitioners with DEA number are now eligible to apply for an X-waiver to treat up to 30 patients by submitting Notice of Intent without required training. This document provides detailed instructions on how to apply for the waiver.

Resources Provided:

Date added: July 24, 2021